Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORION: JX10 in Late-Presenting Acute Ischemic Stroke
jRCT2021250014Phase 3Recruiting
- Sponsor
- TMS Co., Ltd.
- Start
- Feb 2026
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of JX10 in ischemic stroke (5 arms), sponsored by TMS Co., Ltd. Started Feb 2026; status: recruiting.
02
Drugs
JX10
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on jRCT2021250014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2021250014.